Price Alert

Danaher Corporation (DHR)

NYSE: DHR · Real-Time Price · USD

199.48

-4.31 (-2.11%)

At close: Sep 03, 2025, 3:59 PM

200.37

0.45%

Pre-market: Sep 04, 2025, 05:05 AM EDT

-2.11% (1D)

Bid	198.28
Market Cap	142.84B
Revenue (ttm)	24.01B
Net Income (ttm)	3.41B
EPS (ttm)	4.71
PE Ratio (ttm)	42.35
Forward PE	23.73
Analyst	Buy

Ask	202.28
Volume	2,993,433
Avg. Volume (20D)	3,851,120
Open	202.78
Previous Close	203.79
Day's Range	198.72 - 204.04
52-Week Range	171.00 - 279.90
Beta	0.76

About DHR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DHR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DHR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Danaher Corporation is scheduled to release its earnings on Oct 21, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+4.2%

Danaher shares are trading higher after the compan... Unlock content with Pro Subscription

1 month ago

+0.98%

DHR stock has given up its prior loss. Danaher shares were trading lower following Q2 reported financial results.

News

1 day ago · zacks.com

Danaher Gains From Business Strength Amid Persisting Headwinds

DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.

1 week ago · seekingalpha.com

mRNA Biotechs - Long-Term Value Risks Abound

mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c...

1 week ago · zacks.com

Danaher (DHR) Up 6.8% Since Last Earnings Report: Can It Continue?

Danaher (DHR) reported earnings 30 days ago. What's next for the stock?

2 weeks ago · zacks.com

Danaher (DHR) Just Overtook the 200-Day Moving Average

Danaher (DHR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, DHR broke through the 200-day moving average, which suggests a long-te...

3 weeks ago · fool.com

iA Global Buys the Dip in Danaher's Stock Price

On Aug. 5, iA Global Asset Management Inc. disclosed buying 301,028 shares of Danaher (DHR 1.02%), valued at approximately $58.43 million in Q2 2025.

3 weeks ago · businesswire.com

EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Danaher Corporation ...

3 weeks ago · zacks.com

CVS or DHR: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

1 month ago · benzinga.com

Danaher Stock Closes Near Day's High After Key Trading Signal

DHR reverses early down move after Alert

1 month ago · fool.com

Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever

Often, great investing boils down to holding on to great stocks. It can be as simple as that.

1 month ago · zacks.com

International Markets and Danaher (DHR): A Deep Dive for Investors

Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Load More News